63 related articles for article (PubMed ID: 19651373)
21. Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.
Hesselink AT; Meijer CJ; Poljak M; Berkhof J; van Kemenade FJ; van der Salm ML; Bogaarts M; Snijders PJ; Heideman DA
J Clin Microbiol; 2013 Jul; 51(7):2409-10. PubMed ID: 23637297
[TBL] [Abstract][Full Text] [Related]
22. Nucleic acid tests for the detection of alpha human papillomaviruses.
Poljak M; Cuzick J; Kocjan BJ; Iftner T; Dillner J; Arbyn M
Vaccine; 2012 Nov; 30 Suppl 5():F100-6. PubMed ID: 23199952
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and/or neoplasia tissue biopsy specimens.
Tan SE; Garland SM; Rumbold AR; Tabrizi SN
J Clin Microbiol; 2011 Nov; 49(11):3980-2. PubMed ID: 21940480
[TBL] [Abstract][Full Text] [Related]
24. Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR.
Legault V; Burchell A; Goggin P; Nicolau B; Brassard P; Guenoun J; Forest P; Mayrand MH; Franco EL; Coutlée F
J Clin Microbiol; 2011 Nov; 49(11):3977-9. PubMed ID: 21940471
[TBL] [Abstract][Full Text] [Related]
25. Type-specific human papillomavirus infection among heterosexual males examined by peniscopy.
Marques SM; Marques DF; dos Santos Fernandes CE; Scapulatempo ID; Ferreira AM; Padovani CT; Machado AP; de Almeida FG; Tozetti IA
Sex Transm Infect; 2013 Feb; 89(1):82. PubMed ID: 22914680
[No Abstract] [Full Text] [Related]
26. Overview: Detection of Human Papillomavirus in Clinical Samples.
Prakrankamanant P; Wongsena M
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S89-96. PubMed ID: 26817243
[TBL] [Abstract][Full Text] [Related]
27. International standard reagents for HPV detection.
Pagliusi SR; Garland SM
Dis Markers; 2007; 23(4):283-96. PubMed ID: 17627063
[TBL] [Abstract][Full Text] [Related]
28. Effect of glacial acetic acid treatment of liquid-based cytology collections on performance of Cervista HPV HR for detection of high-risk human papillomavirus.
Munson E; Du Chateau BK; Nelson BE; Griep J; Czarnecka J; Amrhein RD; Schroeder ER
J Clin Microbiol; 2012 Jun; 50(6):2129-31. PubMed ID: 22442317
[TBL] [Abstract][Full Text] [Related]
29. A review of methods for detect human Papillomavirus infection.
Abreu AL; Souza RP; Gimenes F; Consolaro ME
Virol J; 2012 Nov; 9():262. PubMed ID: 23131123
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.
Martin IW; Steinmetz HB; Lefferts CL; Dumont LJ; Tafe LJ; Tsongalis GJ
Pathogens; 2012 Sep; 1(1):30-6. PubMed ID: 25436602
[TBL] [Abstract][Full Text] [Related]
31. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media.
Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; LaViers WD; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
J Clin Microbiol; 2013 Aug; 51(8):2702-6. PubMed ID: 23678069
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Onclarity HPV assay on the high-throughput COR system.
Taylor SN; Eckert K; Rucki AA; VanSickler M; Price JA; Gutierrez E; Lizzi M; Cammarata CL; Von Bredow B; Wolfe DM; Harris JM; Gregory SM; Greene WH; Vaughan LM
Expert Rev Mol Diagn; 2021 Mar; 21(3):333-342. PubMed ID: 33849372
[No Abstract] [Full Text] [Related]
33. POC tests: from antigen detection to molecular methods. Future trends.
Ninove L; Nougairede A; Gazin C; Zandotti C; Drancourt M; de Lamballerie X; Charrel RN
J Clin Virol; 2010 Dec; 49(4):304-5. PubMed ID: 20888290
[No Abstract] [Full Text] [Related]
34. How cells hush a viral invader.
Fozouni P; Ott M
Nature; 2018 Dec; 564(7735):193-194. PubMed ID: 30531877
[No Abstract] [Full Text] [Related]
35. Invader threatens black, azov seas.
Travis J
Science; 1993 Nov; 262(5138):1366-7. PubMed ID: 17736801
[No Abstract] [Full Text] [Related]
36. Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.
Munson E; Kroeger L; Balzer S; Amrhein R; Munson KL; Napierala M; Hudspeth R; Dillon PJ
J Clin Microbiol; 2014 Jan; 52(1):331-4. PubMed ID: 24197887
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
38. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
[TBL] [Abstract][Full Text] [Related]
39. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
40. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
Stillman MJ; Day SP; Schutzbank TE
J Clin Virol; 2009 Jul; 45 Suppl 1():S73-7. PubMed ID: 19651372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
